Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 13Terminated 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 15INDUSTRY 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neoplasms 30Prostatic Neoplasms 22Neoplasm Metastasis 20Breast Neoplasms 17Lung Neoplasms 16Colorectal Neoplasms 15Pancreatic Neoplasms 14Leukemia, Myeloid, Acute 14Ovarian Neoplasms 12Lymphoma 12Urinary Bladder Neoplasms 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Burkitt Lymphoma 9Sarcoma, Kaposi 8Pheochromocytoma 8Multiple Myeloma 8Melanoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Endometrial Neoplasms 8Carcinoma, Renal Cell 8Squamous Cell Carcinoma of Head and Neck 7Neuroendocrine Tumors 7Lymphoma, Large B-Cell, Diffuse 7Kidney Neoplasms 7Glioma 7Thyroid Neoplasms 6

Interventions

gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NIH × Neuroectodermal Tumors, Primitive × Clear all
NCT04074135 2026-04-20

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
740 enrolled
EndocrineGastrointestinalNET

von Hippel-Lindau Disease, Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡